Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026
Wednesday, July 15, 2026 1 min read
Key Takeaway: Twist Bioscience Corporation will release its financial results for the fiscal 2026 third quarter on August 3, 2026. The results will cover the period ending June 30, 2026, and will be announced before the market opens. Following the announcement, the company will host a conference call and live audio webcast to discuss the results and provide a business update.
Price reaction · baseline $92.53 (2026-07-14 close) · hit pre-market · clean, no other TWST news in the window
day 0 close · peak
+0.1%
Market Sentiment Analysis
POSITIVE FACTORS
Twist Bioscience is showing growth potential as a mid-cap biotech company.
The upcoming financial results may reflect positive performance.
The company is engaging with analysts and investors through a conference call.
Full Press Release Details
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2026 third quarter ended June 30, 2026, before the opening of the market on August 3, 2026. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business.
Frequently Asked Questions
When will Twist Bioscience report its Q3 financial results?
Twist Bioscience will report its Q3 financial results on August 3, 2026.
What time is the conference call for Q3 results?
The conference call will take place at 8:00 a.m. Eastern Time.
What period do the Q3 results cover?
The Q3 results cover the fiscal period ending June 30, 2026.
How can investors access the Q3 results discussion?
Investors can access the discussion via a live audio webcast.